Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Strategic Transactions.
Altimmune Inc. is acquiring Spitfire Pharma Inc. in a transaction that will move it into non-alcoholic steatohepatitis (NASH)...








